Suivre
Abonner Bayer Pharmaceuticals Corporation; Onyx Pharmaceuticals, Inc.

Bayer Pharmaceuticals Corporation; Onyx Pharmaceuticals, Inc.

Filtre
  • 12.09.2005 – 07:03

    Bayer and Onyx Announce European Marketing Submission for Sorafenib

    West Haven, Connecticut, and Emeryville, California (ots/PRNewswire) - - European Trial to Provide Access to Sorafenib for Individuals with Advanced Renal Cell Carcinoma Bayer Pharmaceuticals Corporation (NYSE: BAY) and Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced that a Marketing Authorization Application (MAA) has been submitted by Bayer to the European Medicines Agency (EMEA) in London for the ...